NOVAVAX INC Debt Securities Available For Sale Excluding Accrued Interest
NOVAVAX INC (NVAX) had Debt Securities Available For Sale Excluding Accrued Interest of $527.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-06
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $527.88M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $561.97M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $494.45M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $494.87M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $527.88M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $561.97M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $494.45M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $494.87M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $358.56M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $468.14M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $392.89M 10-K · filed 2026-02-26 |
| 2024-06-30 | $369.43M 10-Q · filed 2024-08-08 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2020-12-31 | $157.65M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |